vs
Alpha Cognition Inc.（ACOG）与艾伯维（ARGX）财务数据对比。点击上方公司名可切换其他公司
艾伯维的季度营收约是Alpha Cognition Inc.的885.6倍（$2.5B vs $2.8M）。艾伯维净利率更高（35.5% vs -245.5%，领先280.9%）。艾伯维自由现金流更多（$322.4M vs $-7.1M）
艾伯维是总部位于美国伊利诺伊州北芝加哥的制药企业，研发生产的药物覆盖多种疾病治疗领域，可满足多元临床需求，致力于为全球不同病症的患者提供可靠的治疗方案选择。
ACOG vs ARGX — 直观对比
营收规模更大
ARGX
是对方的885.6倍
$2.8M
净利率更高
ARGX
高出280.9%
-245.5%
自由现金流更多
ARGX
多$329.4M
$-7.1M
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $2.8M | $2.5B |
| 净利润 | $-6.9M | $877.2M |
| 毛利率 | — | 89.5% |
| 营业利润率 | -283.7% | 28.9% |
| 净利率 | -245.5% | 35.5% |
| 营收同比 | — | 83.2% |
| 净利润同比 | — | 1.3% |
| 每股收益（稀释后） | $-0.10 | $13.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACOGARGX
| Q4 25 | $2.8M | $2.5B | ||
| Q3 25 | $2.8M | — | ||
| Q2 25 | $1.7M | $1.8B | ||
| Q1 25 | $2.9M | — | ||
| Q4 24 | — | $1.4B | ||
| Q2 24 | — | $901.9M | ||
| Q2 23 | — | $510.9M | ||
| Q2 22 | — | $116.7M |
净利润ACOGARGX
| Q4 25 | $-6.9M | $877.2M | ||
| Q3 25 | $-1.3M | — | ||
| Q2 25 | $-10.5M | $414.8M | ||
| Q1 25 | $-2.0M | — | ||
| Q4 24 | — | $865.6M | ||
| Q2 24 | — | $-32.5M | ||
| Q2 23 | — | $-123.2M | ||
| Q2 22 | — | $-435.9M |
毛利率ACOGARGX
| Q4 25 | — | 89.5% | ||
| Q3 25 | — | — | ||
| Q2 25 | 96.7% | 89.2% | ||
| Q1 25 | 99.6% | — | ||
| Q4 24 | — | 90.2% | ||
| Q2 24 | — | 89.4% | ||
| Q2 23 | — | 91.7% | ||
| Q2 22 | — | 94.5% |
营业利润率ACOGARGX
| Q4 25 | -283.7% | 28.9% | ||
| Q3 25 | -187.0% | — | ||
| Q2 25 | -346.1% | 19.2% | ||
| Q1 25 | -125.9% | — | ||
| Q4 24 | — | 8.7% | ||
| Q2 24 | — | -15.4% | ||
| Q2 23 | — | -40.3% | ||
| Q2 22 | — | -340.5% |
净利率ACOGARGX
| Q4 25 | -245.5% | 35.5% | ||
| Q3 25 | -46.4% | — | ||
| Q2 25 | -632.7% | 23.4% | ||
| Q1 25 | -68.5% | — | ||
| Q4 24 | — | 64.1% | ||
| Q2 24 | — | -3.6% | ||
| Q2 23 | — | -24.1% | ||
| Q2 22 | — | -373.7% |
每股收益（稀释后）ACOGARGX
| Q4 25 | $-0.10 | $13.25 | ||
| Q3 25 | $-0.30 | — | ||
| Q2 25 | $-0.65 | $6.32 | ||
| Q1 25 | $-0.13 | — | ||
| Q4 24 | — | $13.33 | ||
| Q2 24 | — | $-0.55 | ||
| Q2 23 | — | $-2.21 | ||
| Q2 22 | — | $-8.16 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $66.0M | $3.5B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $62.5M | $7.3B |
| 总资产 | $79.7M | $8.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ACOGARGX
| Q4 25 | $66.0M | $3.5B | ||
| Q3 25 | $35.4M | — | ||
| Q2 25 | $39.4M | $2.1B | ||
| Q1 25 | $45.5M | — | ||
| Q4 24 | — | $1.5B | ||
| Q2 24 | — | $1.4B | ||
| Q2 23 | — | $1.1B | ||
| Q2 22 | — | $1.4B |
总债务ACOGARGX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q2 24 | — | $11.0M | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
股东权益ACOGARGX
| Q4 25 | $62.5M | $7.3B | ||
| Q3 25 | $33.9M | — | ||
| Q2 25 | $31.9M | $6.1B | ||
| Q1 25 | $40.8M | — | ||
| Q4 24 | — | $5.5B | ||
| Q2 24 | — | $4.3B | ||
| Q2 23 | — | $2.9B | ||
| Q2 22 | — | $3.0B |
总资产ACOGARGX
| Q4 25 | $79.7M | $8.7B | ||
| Q3 25 | $46.3M | — | ||
| Q2 25 | $45.1M | $7.2B | ||
| Q1 25 | $48.6M | — | ||
| Q4 24 | — | $6.2B | ||
| Q2 24 | — | $4.8B | ||
| Q2 23 | — | $3.2B | ||
| Q2 22 | — | $3.2B |
负债/权益比ACOGARGX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q2 24 | — | 0.00× | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.9M | $323.3M |
| 自由现金流经营现金流 - 资本支出 | $-7.1M | $322.4M |
| 自由现金流率自由现金流/营收 | -252.6% | 13.0% |
| 资本支出强度资本支出/营收 | 5.3% | 0.0% |
| 现金转化率经营现金流/净利润 | — | 0.37× |
| 过去12个月自由现金流最近4个季度 | $-20.7M | $594.5M |
8季度趋势，按日历期对齐
经营现金流ACOGARGX
| Q4 25 | $-6.9M | $323.3M | ||
| Q3 25 | $-5.3M | — | ||
| Q2 25 | $-6.1M | $361.8M | ||
| Q1 25 | $-2.0M | — | ||
| Q4 24 | — | $41.9M | ||
| Q2 24 | — | $-124.7M | ||
| Q2 23 | — | $-285.4M | ||
| Q2 22 | — | $-494.5M |
自由现金流ACOGARGX
| Q4 25 | $-7.1M | $322.4M | ||
| Q3 25 | $-5.4M | — | ||
| Q2 25 | $-6.1M | $356.6M | ||
| Q1 25 | $-2.1M | — | ||
| Q4 24 | — | $40.9M | ||
| Q2 24 | — | $-125.5M | ||
| Q2 23 | — | $-285.9M | ||
| Q2 22 | — | $-494.7M |
自由现金流率ACOGARGX
| Q4 25 | -252.6% | 13.0% | ||
| Q3 25 | -188.8% | — | ||
| Q2 25 | -370.9% | 20.1% | ||
| Q1 25 | -72.0% | — | ||
| Q4 24 | — | 3.0% | ||
| Q2 24 | — | -13.9% | ||
| Q2 23 | — | -56.0% | ||
| Q2 22 | — | -424.0% |
资本支出强度ACOGARGX
| Q4 25 | 5.3% | 0.0% | ||
| Q3 25 | 2.6% | — | ||
| Q2 25 | 0.5% | 0.3% | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | — | 0.1% | ||
| Q2 24 | — | 0.1% | ||
| Q2 23 | — | 0.1% | ||
| Q2 22 | — | 0.2% |
现金转化率ACOGARGX
| Q4 25 | — | 0.37× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.87× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.05× | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
